The prognostic value and clinical utility of estrogen and progesterone receptors in endometrial carcinoma
- 1 March 2000
- journal article
- Published by Elsevier in Primary Care Update for OB/GYNS
- Vol. 7 (2) , 55-59
- https://doi.org/10.1016/s1068-607x(00)00021-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Prognostic Significance of Progesterone Receptor Immunohistochemistry in Endometrial CarcinomaGynecologic Oncology, 1998
- Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancersBritish Journal of Cancer, 1996
- Prognostic significance of hormone receptors in endometrial cancerCancer, 1993
- Estrogen and progesterone receptors in endometrial cancer and their prognostic relevanceGynecologic Oncology, 1990
- Estrogen and progesterone receptor content of endometrial carcinomas: Comparison of total tissue versus cancer component analysisGynecologic Oncology, 1990
- The predictive value of progesterone receptor levels in endometrial cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancerGynecologic Oncology, 1988
- Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometriumAmerican Journal of Obstetrics and Gynecology, 1988
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985